Aerts, Hugo J W L <br/><br/>
Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Jan 2012 
 - 73-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2011.06.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--diagnostic imaging<br/>Chemoradiotherapy--methods<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Fluorodeoxyglucose F18--pharmacokinetics<br/>Humans<br/>Lung Neoplasms--diagnostic imaging<br/>Middle Aged<br/>Positron-Emission Tomography--methods<br/>Prospective Studies<br/>Radiopharmaceuticals--pharmacokinetics<br/>Radiotherapy Planning, Computer-Assisted<br/>Tomography, X-Ray Computed--methods<br/>Tumor Burden--radiation effects<br/>Gemcitabine